Latest filing published 19 Nov 2024 for R1 RCM Inc. /DE.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph Gerard Flanagan discloses dealings in 3 companies, chiefly R1 RCM Inc., R1 RCM Inc. /DE and GoHealth, Inc. Over a trading history stretching from 9 July 2015 to 19 November 2024, the count stands at 69 filings.
On the open market, the record shows 2 purchases worth €180k and 11 sales worth €31.6M. Netting one side against the other leaves €31.5M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 42 share grants and 12 option exercises.
The latest filing, published on 19 November 2024, reports a transaction of €47.0M in R1 RCM Inc. /DE. The last insider purchase was made public on 16 March 2020, 2,412 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations